Danaher Corp., US2358511028

Danaher stock: Wall Street Zen upgrade adds to bullish analyst view

Published on 10/31/2026 at 10:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher stock drew fresh support from a Wall Street Zen upgrade to Buy. Analysts also lifted several price targets after the company's third-quarter report.

Analysts lift Danaher outlook

  • Wall Street Zen upgraded Danaher from Hold to Buy on October 26.
  • Several firms raised price targets after the company reported stronger third-quarter results.
  • Management increased its 2026 adjusted earnings outlook while respiratory demand remained a headwind.
Danaher Corp., US2358511028, Illustration mit AI erstellt.

Danaher stock entered the final week of October with a more constructive analyst backdrop after Wall Street Zen upgraded the shares from Hold to Buy on Monday, October 26. MarketBeat said the move added to a Moderate Buy consensus among analysts.

Target increases follow earnings

MarketBeat also reported several target increases after Danaher's third-quarter results. TD Cowen and JPMorgan raised their targets to USD 270, while Barclays moved to USD 260 and Stifel Nicolaus also set a USD 260 objective. The consensus target cited in the report was USD 242.91.

The analyst moves followed Danaher's October 21 earnings release. Quarterly adjusted earnings per share reached USD 2.11, ahead of the USD 1.92 consensus cited by MarketBeat, while revenue rose 8.3 percent year over year to USD 6.55 billion. Management also raised its full-year 2026 adjusted earnings outlook.

Execution improves outside respiratory testing

Danaher's operating picture remains mixed. The company reported stronger execution across its life-sciences, biotechnology and diagnostics businesses, while respiratory testing continued to weigh on reported growth. That combination explains why analysts have focused on the quality of underlying demand as well as the higher earnings outlook.

For investors, the revised guidance improves visibility into the remainder of 2026, but the valuation and the path to 2027 growth remain important considerations. MarketBeat cited tariff pressure and a cautious initial view for 2027 as risks alongside the improved current-year outlook.

The real-time quote of Danaher Corp stock was 209.35 euros on Lang & Schwarz at 10:18 CET on Saturday, October 31, 2026.

Danaher Corp stock at a glance

  • Company: Danaher Corp.
  • ISIN: US2358511028
  • WKN: 866197
  • Ticker: DHR
  • Home exchange: New York Stock Exchange
  • Lang & Schwarz quote: 209.35 euros, October 31, 2026, 10:18 CET

US market conditions can be followed in the S&P 500 market overview.

More news and analyses on Danaher Corp stock

Disclaimer...
en | US2358511028 | DANAHER CORP. | boerse | 70438176 |